—

BB Biotech AG(BION.SW)— 同类公司组

数据截至2026-11-16 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

BB Biotech AG的Closelook综合评分为60/100,在同类公司组内排名第6位(共7家)——组内评分最高的是Halozyme Therapeutics Inc(72/100)。

名称综合动量质量估值信号距52周高点
BION.SW BB Biotech AG60749571ok5.1%
HALO Halozyme Therapeutics Inc72689449info28%
ARGX.BR Argen-X64797525ok5.1%
UCB.BR UCB SA64757042info2%
ARGX argenx NV ADR63707425ok11.4%
PTGX Protagonist Therapeutics Inc61647218info22.4%
CORT Corcept Therapeutics Incorporated60526632info45.2%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-16

Quick answers

BB Biotech AG在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Halozyme Therapeutics Inc (HALO)、Argen-X (ARGX.BR)、UCB SA (UCB.BR)、argenx NV ADR (ARGX)、Protagonist Therapeutics Inc (PTGX)、Corcept Therapeutics Incorporated (CORT)。

BION.SW相对同类公司的评分如何?

BB Biotech AG的综合评分为60/100,组内排名第6位(共7家),截至2026-11-16;组内最高综合评分为Halozyme Therapeutics Inc(72/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.